Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV
Kumari G. Lokugamage(The University of Texas Medical Branch at Galveston), Vineet D. Menachery(The University of Texas Medical Branch at Galveston)
Cited by 188
Related Papers
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
|Nature|2021|781
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
|bioRxiv (Cold Spring Harbor Laboratory)|2020|207
Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
|PLoS Biology|2021|86
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3
|Journal of Virology|2023|44
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
|bioRxiv (Cold Spring Harbor Laboratory)|2021|25